Endocrine Testing Market worth $xx million by 2027
The report "Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) -Global Forecast to 2027", size is projected to reach USD xx million by 2027 from USD xx million in 2022, at a CAGR of xx% during the forecast period.
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/endocrine-testing-market-160907268.html
Market is driven by factors such as the rising cases of endocrine diseases and their increasing diagnosis. On the other hand, the high cost of certain endocrine tests is expected to limit market growth to a certain extent in the coming years.
“The insulin segment accounted for the largest market share in the Endocrine Testing market, type, during the forecast period”
The Endocrine Testing Market is segmented into thyroid test, insulin test, human chorionic gonadrotrophin test, prolactin test, luteinizing test, Progesterone, Estradiol (E2), Follicle Stimulating Hormone (FSH) test, Dehydroepiandrosterone sulfate (DHEAS) test, Testosterone Test, Cortisol Test, and other tests. In 2021, insulin segment dominated the market due to the high volume of insulin test and the rising prevalence of diabetes.
“Immunoassay segment accounted for the largest market share”
Based on the technology, the Endocrine Testing Market is segmented into immunoassay, tandem mass spectroscopy, clinical chemistry and other technology. In 2021, immunoassay segment held the dominating share, owing to its wide scale application in the diagnosis and research of diseases, .
“APAC region accounted for the highest CAGR”
The global Endocrine Testing market is divided into five regions: North America, Asia-Pacific, Europe, and Rest of the World. According to the regional analysis, the North America region is expected to retain a dominant market share in 2021 and in the coming years. The North America Endocrine Testing market is being fueled by the rising in the cases of endocrine disorders, expanding geriatric population, and advanced healthcare and research infrastructure. Asia Pacific, on the other hand, will experience significant growth in the coming years due to the emerging medical infrastructure, and increasing awareness of the endocrine diseases diagnosis. The major players operating in this market are Abbott Laboratories (US), AB Sciex, Agilent Technologies (US), bioMerieux SA (France), and Bio Rad Laboratories (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Endocrine Testing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
